ASMB Assembly Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ASMB

Price (delayed)

$12.68

Market cap

$69.52M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$13.38

Enterprise value

$52.02M

Assembly Bio is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the ...

Highlights
ASMB's EPS is up by 42% year-on-year and by 22% since the previous quarter
Assembly Biosciences's net income has increased by 34% YoY and by 16% QoQ
The company's debt has surged by 155% QoQ but it fell by 32% YoY
The equity has plunged by 50% YoY
ASMB's quick ratio is down by 49% since the previous quarter and by 42% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.assemblybio.com
Peers: IRWD ENZN CPIX

Key stats

What are the main financial stats of ASMB
Market
Shares outstanding
5.48M
Market cap
$69.52M
Enterprise value
$52.02M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.69
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$61.2M
EBITDA
-$60.75M
Free cash flow
$22.51M
Per share
EPS
-$13.38
Free cash flow per share
$4.92
Book value per share
$7.51
Revenue per share
$0
TBVPS
$29.89
Balance sheet
Total assets
$136.82M
Total liabilities
$95.73M
Debt
$2.34M
Equity
$41.1M
Working capital
$94.56M
Liquidity
Debt to equity
0.06
Current ratio
3.41
Quick ratio
3.32
Net debt/EBITDA
0.29
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-72.4%
Return on equity
-117.7%
Return on invested capital
-144.8%
Return on capital employed
-62.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ASMB stock price

How has the Assembly Biosciences stock price performed over time
Intraday
-5.09%
1 week
-5.44%
1 month
-2.91%
1 year
1,184.7%
YTD
1,446.15%
QTD
-4.66%

Financial performance

How have Assembly Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$71.81M
Net income
-$61.23M
Gross margin
N/A
Net margin
N/A
Assembly Biosciences's net income has increased by 34% YoY and by 16% QoQ
Assembly Biosciences's operating income has increased by 24% YoY and by 4.3% QoQ

Growth

What is Assembly Biosciences's growth rate over time

Valuation

What is Assembly Biosciences stock price valuation
P/E
N/A
P/B
1.69
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ASMB's EPS is up by 42% year-on-year and by 22% since the previous quarter
The price to book (P/B) is 78% higher than the last 4 quarters average of 1.0 and 48% higher than the 5-year quarterly average of 1.2
The equity has plunged by 50% YoY

Efficiency

How efficient is Assembly Biosciences business performance
The return on equity has declined by 44% year-on-year
The ROIC has increased by 37% from the previous quarter but it has decreased by 13% YoY
The company's return on assets rose by 25% QoQ but it fell by 3% YoY

Dividends

What is ASMB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ASMB.

Financial health

How did Assembly Biosciences financials performed over time
The total assets is 43% more than the total liabilities
The total assets has soared by 165% from the previous quarter and by 34% YoY
Assembly Biosciences's current ratio has shrunk by 51% QoQ and by 43% YoY
The company's debt is 94% lower than its equity
The debt to equity has soared by 200% from the previous quarter and by 50% YoY
The company's debt has surged by 155% QoQ but it fell by 32% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.